Chronic insulin exposure and metabolic stressors in ischemic conditions activate p38 MAPK and enhance insulin receptor substrate 1/2 (IRS1/2) degradation, culminating in AKT inactivation and eventual myocyte death and heart failure [13]. The gene discussed is IRS1; the disease is heart failure.